United States · 
Who invested in Silarus Therapeutics?
Silarus Therapeutics's investors include Avalon Ventures and GlaxoSmithKline.
United States · Series A startup
Who invested in Silarus Therapeutics
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$10Mraised across 1 round since 2014, from 1 source
- Latest round
- Series A, $10MSept 2014
- Investors
- 2
The rounds
- Sept 2014
Everyone who backed them
Avalon VenturesVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Silarus Therapeutics
How much has Silarus Therapeutics raised?
Silarus Therapeutics has raised $10M across 1 round since 2014.
When did Silarus Therapeutics last raise?
Silarus Therapeutics's most recent round was a Series A of $10M in Sept 2014.
What was Silarus Therapeutics's biggest round?
Its most recent round, $10M in Sept 2014, is also its largest on record.
Who backed Silarus Therapeutics first?
Silarus Therapeutics's first round on record, in Sept 2014, was backed by Avalon Ventures and GlaxoSmithKline.
What stage is Silarus Therapeutics at?
Silarus Therapeutics's latest named round is a Series A, in Sept 2014.
Where is Silarus Therapeutics based?
Silarus Therapeutics is based in the United States.
Companies like Silarus Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.